Shagbark Hickory Allergy Shots (SCIT)
Shagbark hickory (Carya ovata) is the most allergenic species in the Carya genus — ranked alongside box-elder and willow in the highest severity tier of classical pollen-count studies — and the dominant hickory aeroallergen in the Mid-Atlantic. No IUIS-named pollen allergen exists for C. ovata and no SCIT RCT has been conducted, but intra-Carya cross-reactivity is essentially complete, so a pecan-anchored Juglandaceae SCIT extract covers shagbark patients via genus-level cross-protection.
Shagbark Hickory Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to shagbark hickory — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of shagbark hickory allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of shagbark hickory immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of shagbark hickory extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for shagbark hickory allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing shagbark hickory extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription shagbark hickory immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat shagbark hickory allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Shagbark Hickory?
The biology, taxonomy, and clinical fingerprint of Shagbark Hickory — the foundation of how SCIT targets it.
Carya ovata (shagbark hickory) is identified by its distinctive shaggy bark. Classical pollen-count studies rank it as the most allergenic species in the Carya genus — alongside box-elder and willow in the highest allergy-impact tier — yet no pollen allergen has been formally named at WHO/IUIS.
- Scientific name
- Carya ovata (Mill.) K.Koch
- Family
- JuglandaceaeWalnut family
- Type
- Deciduous tree pollen
- Native to
- Eastern and central US, especially Mid-Atlantic; USDA PLANTS distribution includes most of the eastern hardwood region
- Allergen proteins
- NO IUIS-named pollen allergen for Carya ovata as of May 2026 — no molecular characterization published for C. ovata pollen proteinsIntra-Carya genus cross-reactivity to pecan pollen proteins, including the 17 IgE-binding proteins identified by Cuevas-Zuviría et al. (J Proteomics 2021), is assumed in clinical practiceNamed Carya allergens at WHO/IUIS (Car i 1, Car i 2, Car i 4) are all kernel food proteins from pecan — NOT from shagbark hickory pollenShagbark hickory kernel food allergy is cross-reactive with pecan Car i 1/2/4 at the kernel level but distinct from pollen allergy
- Particle size
- ~30–45 μm
- Avoidance difficulty
- Nearly impossible
How Shagbark Hickory Allergy Presents
Symptoms by body system — useful for distinguishing Shagbark Hickory sensitivity from overlapping allergies and infections.
Respiratory (Pollen — Inhalant Allergy)
- Moderate-to-severe sneezing and rhinorrhea during April–May shagbark hickory pollen season in the Mid-Atlantic and eastern US
- Nasal congestion ranked among the highest-severity Carya pollen reactions per classical pollen-count studies
- Itchy, swollen nasal passages during catkin release — shagbark pollen counts rank in the same severity tier as box-elder and willow
- Allergic asthma exacerbations in sensitized patients during peak Carya season
- Post-nasal drip and chronic cough from the 4–6 week shagbark season
Ocular
- Bilateral eye itching and watering during the April–May shagbark season in the Mid-Atlantic
- Conjunctival redness and swelling on high-pollen days
- Morning eyelid puffiness from overnight pollen accumulation
- Photophobia during severe allergic conjunctivitis episodes
Dermal
- KERNEL DISAMBIGUATION: Hickory kernel food reactions driven by storage proteins cross-reactive with pecan Car i 1/2/4 are NOT treated by shagbark pollen SCIT. If you experience systemic reactions after eating hickory nuts, seek evaluation for kernel food allergy independently of pollen SCIT.
- Contact dermatitis from hickory tree sap or green hull handling
- Atopic dermatitis flares coinciding with spring Carya pollen season in sensitized patients
Systemic
- Fatigue and sleep disruption during the April–May shagbark season — amplified by concurrent oak and ash exposure in the eastern US
- Impaired outdoor activity during prime spring season in Mid-Atlantic forests where C. ovata is abundant
- Quality-of-life impairment comparable to severe oak allergy during peak Carya pollen weeks
- Cumulative burden from co-sensitization to multiple spring tree allergens common in the Mid-Atlantic
Shagbark hickory has been ranked as the most allergenic Carya since the classical pollen-count studies — alongside box-elder and willow in the top severity tier. In the Mid-Atlantic, I treat shagbark-positive patients with a Carya-anchored mix at standard clinical doses, even without a shagbark-specific RCT, because intra-genus cross-reactivity covers most patients with one Carya extract.
When & Where Shagbark Hickory Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: April–May across the eastern and central US, especially Mid-Atlantic (DC, Baltimore, Richmond, Philadelphia)· ~4–6 weeks; overlaps with peak oak and ash season in the Mid-Atlantic spring window
US Exposure Map
8 high-intensity statesWhat Shagbark Hickory Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Shagbark hickory pollen cross-reactivity follows the Carya genus pattern — essentially complete within Carya, moderate-to-high with Juglans (walnut) at the Juglandaceae family level. The Cuevas-Zuviría 2021 immunoproteomics of pecan pollen identified 17 IgE-binding proteins whose overlap with shagbark is assumed in clinical practice but has not been directly characterized.
Within-Carya genus; essentially complete pollen cross-reactivity; pecan is the best-characterized Carya species (27.8% US rhinitis sensitization, Hoffman 1996)
Combined Carya SCIT preparation — built on this near-complete cross-reactivity
Kernel storage-protein cross-reactivity with pecan Car i 1/2/4 and walnut Jug r 1/2/4 — NOT addressed by pollen SCIT
Is SCIT Right for Your Shagbark Hickory Allergy?
Answer five questions to assess whether shagbark hickory SCIT or a Carya-anchored mix is appropriate for your Mid-Atlantic spring allergy profile.
How severe are your April–May spring allergy symptoms in the Mid-Atlantic or eastern US?
The Shagbark Hickory SCIT Protocol
Shagbark hickory SCIT uses non-standardized Carya extract — typically the hickory-pecan mix or pecan preparation that exploits essentially complete intra-Carya cross-reactivity. A dedicated C. ovata-specific extract is available from some manufacturers but adds minimal clinical benefit given the genus-level cross-reactivity. Mid-Atlantic patients benefit from initiating build-up in fall or winter to reach maintenance before the April Carya season.
Injections begin at 1:10,000 w/v and increase incrementally. Mid-Atlantic patients should initiate build-up in fall (September–November) to reach or approach maintenance dose before the April shagbark season. Because shagbark ranks highest in Carya pollen severity, starting during active season is particularly to be avoided. Patients with hickory kernel food allergy must continue strict kernel avoidance and epinephrine carry throughout SCIT. With at-home SCIT through Curex, the first injection and every dose increase are supervised live over Zoom by the prescribing allergist, with a prescribed epinephrine auto-injector confirmed on hand and a 30-minute self-observation after each injection.
Monthly maintenance at the target dose sustains Carya genus-level tolerance. In the Mid-Atlantic where shagbark is the dominant hickory, the maintenance dose provides cross-protection to all co-occurring Carya species via the shared pollen protein pool documented by Cuevas-Zuviría 2021 for pecan.
Lasting benefit of 7–12+ years expected with full course completion. SCIT discontinuation has no impact on hickory kernel food allergy management.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Shagbark Hickory SCIT
Shagbark hickory pollen SCIT has no species-specific RCT and no formally named pollen allergen. Efficacy is extrapolated from genus-level Carya data (Hoffman 1996 sensitization rates, Bucholtz series, and Cuevas-Zuviría 2021 immunoproteomics) and the general inhalant SCIT evidence framework.
- Carya/hickory sensitization in NYC tree-allergic patients27%Bucholtz et al. NYC series — 27.1% of 371 tree-allergic patients reacted to pecan/hickory pollen
- Pecan SPT positivity in US children with rhinitis (genus-level proxy)28%Hoffman 1996 (cited Thermo Fisher t22): 27.8% SPT+ to pecan in 209 US rhinitis patients
- General inhalant SCIT efficacy for non-standardized tree pollen extracts55%Cox L et al., J Allergy Clin Immunol 2011 — AAAAI Practice Parameter general framework
No shagbark-specific SCIT RCT exists. Shagbark hickory's distinction as the most allergenic Carya species in classical pollen-count studies (ranked alongside box-elder and willow) is based on airborne pollen severity ratings, not controlled immunotherapy trials. Clinical treatment follows genus-level Carya principles — a single Carya extract providing essentially complete coverage across shagbark, pecan, mockernut, and other hickories — with the Hoffman 1996 and Bucholtz data providing the best available clinical magnitude evidence.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Shagbark Hickory SCIT Side Effects
Shagbark hickory SCIT side effects follow the standard inhalant SCIT profile. Because shagbark ranks highest in Carya pollen severity, Mid-Atlantic patients should strongly prefer initiating build-up in fall or winter to minimize reactivity from active spring co-exposure.
Local reactions
4 documentedSystemic reactions
4 documentedCRITICAL: Patients with confirmed hickory kernel food allergy (Car i 1/2/4-driven from pecan or cross-reactive hickory kernels) must continue strict kernel avoidance and carry an epinephrine auto-injector throughout and after pollen SCIT. A 30-minute self-observation follows every shagbark SCIT dose; with at-home SCIT through Curex the serum is sterile-compounded to USP <797>, a prescribed epinephrine auto-injector is confirmed on hand, and the first dose and every dose change are supervised live over Zoom by a board-certified allergist.
SCIT vs Alternatives for Shagbark Hickory
Shagbark-hickory-allergic patients in the Mid-Atlantic have four main options: Carya-anchored SCIT (covering shagbark via genus-level cross-protection), at-home sublingual drops, avoidance, and daily seasonal medications.
| Criterion | SCITBest | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Uncertain — no shagbark-specific RCT; genus-level Carya evidence from Hoffman 1996 and Bucholtz series | Uncertain — no shagbark pollen SLIT RCT; off-label Carya drops available | Low — shagbark hickory is abundant in Mid-Atlantic forests and suburban areas | Moderate — antihistamines + nasal corticosteroids for mild-to-moderate symptoms |
| 5-yr cost | $3,500–$15,000 over 5 years | $39/month via Curex (at-home sublingual drops, no needles) | Low — HEPA, pollen masks, closed windows | $500–$2,000 over 5 years |
| Duration | 3–5 year course | 3–5 year course | Indefinite — no tolerance change | Indefinite — seasonal use |
| Convenience | Weekly at-home self-injection with Curex; fall/winter start preferred for Mid-Atlantic patients; first dose and dose changes supervised live over Zoom | Daily at-home — no clinic required | High inconvenience during prime spring season | High convenience |
| Safety | Excellent with a prescribed epinephrine auto-injector on hand, a 30-min self-observation, and live Zoom supervision of every dose change | Favorable for pollen; does not affect kernel food allergy risk | Safe | Generally safe |
| Lasting effect | 7–12+ years after completion | Emerging data | None — symptoms return each April | None — must take every season |
SCITBest
SLIT
Avoidance
Medications
SCIT anchored to the Carya genus is the standard immunotherapy approach for shagbark hickory allergy — exploiting near-complete intra-genus cross-reactivity. Curex now offers this as a weekly at-home allergy shot at $129/month, with a serum sterile-compounded to USP <797>, a prescribed epinephrine auto-injector confirmed on hand, and the first dose and every dose change supervised live over Zoom by a board-certified allergist. Sublingual drops remain a general allergy modality some providers offer for patients who prefer a needle-free option.
What Shagbark Hickory SCIT Actually Costs
Shagbark hickory SCIT is covered by most major US insurers under standard allergy immunotherapy benefits when prescribed by a board-certified allergist with documented sensitization. Shagbark is typically included in an eastern multi-tree mix — pre-authorization should specify the Carya component and overall tree mix composition. Curex at-home IgE testing identifies specific shagbark hickory sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
Flat monthly subscription — includes consult, prescription, and at-home dosing for sublingual immunotherapy.
See if you qualifyStop guessing about your shagbark hickory allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Shagbark Hickory SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
The 'most allergenic' ranking for shagbark hickory comes from classical pollen-count studies that measured the volume and particulate characteristics of pollen from different Carya species — not from molecular allergen characterization or controlled immunotherapy trials. Shagbark's pollen is particularly abundant, light, and efficiently airborne in the Mid-Atlantic hardwood ecosystem, which drives higher patient sensitization rates in areas where C. ovata dominates compared with regions where bitternut (C. cordiformis) or mockernut (C. tomentosa) are more prevalent. The IUIS allergen-naming process requires protein-level characterization, not pollen-count data — which is why shagbark can be the most clinically prominent Carya species while still lacking a formally named allergen.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.